EUVIMEDEUVIMED entdecken
Crossref

Mendelian Randomization Study of Sex Hormone Binding Globulin and Its Influence on Adverse Pregnancy Outcomes

Han Wu, Yiying Jin, Qiuhui Pan, Feng Cheng, Chaoyan Yue

American Journal of Reproductive Immunology · 2025

DOI: 10.1111/aji.70139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Han Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for…. Hauptthemen laut MEDLINE: Sex Hormone-Binding Globulin, Abortion, Spontaneous, Pre-Eclampsia, Diabetes, Gestational. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Basic Research Program, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The relationship between sex hormone‐binding globulin (SHBG) levels and the risk of adverse pregnancy outcomes (APOs) remains controversial. A two‐sample Mendelian randomization (MR) study was performed to clarify the causality of SHBG on the risk of APO.

Methods

Significant single‐nucleotide polymorphisms (SNPs) associated with SHBG levels were obtained from the genome‐wide association study (GWAS) in the European population. Summary statistics of the number of spontaneous miscarriages, preeclampsia, gestational diabetes mellitus (GDM), intrahepatic cholestasis of pregnancy (ICP), and female infertility were utilized as the outcome. The causality was examined primarily by inverse‐variance weighted (IVW), along with MR‐Egger regression, weighted median estimator, and weighted mode method.

Results

Based on the IVW model, every genetically predicted standard deviation (SD) increase in SHBG levels was causally associated with 0.023 SDs decrease of the number of spontaneous miscarriages (Beta ± SE: −0.023 ± 0.010, p = 0.018), 11.3% decrease of the risk of preeclampsia (OR = 0.887, 95% CI: 0.806–0.977, p = 0.015), 17% decrease of the risk of GDM (OR = 0.830, 95% CI: 0.753–0.914, p = 0.000), 23.6% decrease of the risk of ICP (OR = 0.764, 95% CI: 0.584–0.999, p = 0.049), and 14% decrease of the risk of infertility (OR = 0.860, 95% CI: 0.777–0.951, p = 0.003).

Conclusion

Our study indicated that the increased levels of SHBG could significantly reduce the risk of APO. SHBG may be helpful as the indicator for preconception risk assessment and pregnancy risk monitoring. These findings are limited to European and require further validation in diverse populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sex Hormone-Binding GlobulinAbortion, SpontaneousPre-EclampsiaDiabetes, GestationalInfertility, FemaleHumansFemalePregnancyMendelian Randomization AnalysisPolymorphism, Single NucleotideGenome-Wide Association StudyPregnancy OutcomeCholestasis, IntrahepaticPregnancy Complications

Stichwörter der Autor:innen

Mendelian randomizationadverse pregnancy outcomescausationpregnancysex hormone‐binding globulin

Substanzen

Sex Hormone-Binding GlobulinSHBG protein, human

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University,…
  • Department of Clinical Laboratory, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Faculty of Medical Laboratory Science, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory of Clinical Molecular Diagnostics for Pediatrics, Shanghai, China.
  • Hainan Branch, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Sanya, China.
  • Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai Basic Research Program
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Wu, H., Jin, Y., Pan, Q., Cheng, F., & Yue, C. (2025). Mendelian Randomization Study of Sex Hormone Binding Globulin and Its Influence on Adverse Pregnancy Outcomes. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70139

Vancouver

Wu H, Jin Y, Pan Q, Cheng F, Yue C. Mendelian Randomization Study of Sex Hormone Binding Globulin and Its Influence on Adverse Pregnancy Outcomes. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70139

BibTeX
@article{Wu2025,
  author = {Wu, Han and Jin, Yiying and Pan, Qiuhui and Cheng, Feng and Yue, Chaoyan},
  title = {Mendelian Randomization Study of Sex Hormone Binding Globulin and Its Influence on Adverse Pregnancy Outcomes},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  doi = {10.1111/aji.70139}
}
Kostenlos starten →